Companies formed
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
NightStar Therapeutics (acquired by Biogen)
A private biopharmaceutical company focused on the development of therapies for retinal dystrophies. NightStar Therapeutics was acquired by Biogen in June 2019.
Incorporated in January 2014
Origin: Oxford University, Nuffield Department of Clinical Neurosciences
2013
Oxford Mestar
A rapidly grown, energetic company specialising in translational and regenerative medicine.
Incorporated in December 2013
Origin: Oxford University, Institute of Biomedical Engineering
MuOx
Duchenne Muscular Dystrophy.
Incorporated in November 2013
Origin: Oxford University, Department of Chemistry
Oxford Biotrans
Develops and commercialises enzymatic process technologies that yield high-value chemical compounds.
Incorporated in September 2013
Origin: Oxford University, Department of Chemistry
Perspectum Diagnostics
Developing solutions for major unmet needs in diagnostic medicine in multiple internal organs. In the first instance the focus will be on, the detection and the accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states in these organs.
Incorporated in April 2013
Origin: Oxford University, Radcliffe Department of Medicine
2012
Run3D
Offering the most accurate assessment of running biomechanics that modern science is able to provide.
Incorporated in December 2012
Origin: Oxford University, Department of Engineering Science
Oxford VacMedix
Cellular immunity vaccines.
Incorporated in September 2012
Origin: Oxford University, Weatherall Institute of Molecular Medicine
Oxehealth
Revolutionary healthcare technology that measures medical vital signs without physical contact.
Incorporated in August 2012
Origin: Oxford University, Institute of Biomedical Engineering
Intelligent Ultrasound (Medaphor)
Intelligent Ultrasound develops and sells products and services that make medical ultrasound imaging a more effective diagnostic tool and help hospitals provide a better quality, more consistent ultrasound imaging service for their patients.
Incorporated in July 2012
Origin: Oxford University, Institute of Biomedical Engineering
2011
Oxford Cancer Biomarkers
Pioneering biomarker technologies for cancer therapies.
Incorporated in December 2011
Origin: Oxford University, Radcliffe Department of Oncology
Oxford Imaging Detectors
Developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level.
Incorporated in October 2011
Origin: Oxford University, Department of Materials
Oxford Multi Spectral
Develops and manufacturers multispectral digital scanners based upon a patented flatbed scanner design.
Incorporated in September 2011
Origin: Oxford University, Faculty of Classics
Oxtex
Tissue expander solutions for the primary use in reconstructive and dental surgery.
Incorporated in July 2011
Origin: Oxford University, Department of Materials
First Light Fusion (Oxyntix)
Energy from Fusion.
Incorporated in July 2011
Origin: Oxford University, Department of Engineering Science
Cella Energy
Advanced materials and technologies in safe, lightweight, high performance hydrogen storage technology.
Incorporated in January 2011
Origin: Oxford University, Science and Technology Facilities Council
2010
Oxford PV
Oxford PV are developing new photovoltaic cells that will provide a sustainable solar energy source.
Incorporated in November 2010
Origin: Oxford University, Department of Physics
IXO Therapeutics
A biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases.
Incorporated in November 2010
Origin: Oxford University, Department of Biochemistry
Tidal – Kepler Energy
Kepler Energy Limited develops a second-generation tidal turbine, which has the potential to harness tidal energy more efficiently and cheaply, using a device which is simpler, more robust and more scalable than current designs.
Incorporated in October 2010
Origin: Oxford University, Department of Engineering Science
Oxems
Oxford Electromagnetic Solutions - smart asset management through underground network visibility.
Incorporated in June 2010
Origin: Oxford University, Department of Engineering Science
Oxepi
Oxidative Enzymes for the Pulp and Paper Industry.
Incorporated in February 2010
Origin: Oxford University, Department of Chemistry
© Oxford University Innovation